Cediranib affects tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts (EOC-PDX). (July 2016) - Decio, A.; Cesca, M.; Bizzaro, F.; Bani, M.R.; Belotti, D.; Giavazzi, R.